Hims Hers Health Shares Rally on Novo Nordisk Deal
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesHims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
A grounded, practical look at whether Micron Technology stock can move meaningfully in the next 12 months. Explore dr...
When a company in niche hardware makes a bold strategic move, the stock can leap. This piece explains how unusual mac...
This article breaks down agilysys (agys) 2026 earnings, explaining what the metrics mean for investors. Learn how to ...
A fresh wave of AI-driven momentum is reshaping Amazon's outlook, and investors are paying close attention. This arti...
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
In a choppy crypto market, Zcash faced a dramatic turn after its development team resigned amid board tensions. This ...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
A short-seller report rattled SoFi stock, but headlines don’t always tell the full story. This analysis digs into the...
A leading AI investor says up to 80% of jobs could be AI-enabled by 2030, a view that’s fueling a new wave of policy ...
The CDC confirms 41 people are under hantavirus monitoring in the U.S., with travel-linked exposures tied to a cruise...